Soon there will be drugs created by artificial intelligence.

Creating new drugs takes a lot of time from pharmacists and all people involved in the process. In addition to creating a chemical formula, it is necessary to conduct a series of studies to determine the degree of impact of a novelty on a person. A separate stage - this test and laboratory tests. In order to simplify and speed up the process of creating new vital components, experts have developed an artificial intelligence system, specially sharpened for these purposes.

The technology itself works on the principle of the interaction of two interconnected neural systems, designated as “student” and “teacher”. At the time of creation of the drug, the selected molecule with the necessary properties is taken as the basis. However, to achieve one hundred percent result, the model model needs to be “reconfigured” by adding and removing certain atoms. Similar information has the AI ​​unit "Teacher".Information about more than 1.5 million molecules is loaded into its database, allowing to determine variants from interaction with each other. The “Pupil” neurosystem receives knowledge about the interaction of substances from the “Teacher” and offers the most effective combinations of components.

The technology is based on the ReLeaSE system, a well-known technique used by pharmacists around the world. In the process of analysis, ReLeaSE takes into account the values ​​of the most significant indicators - solubility in water, melting points, degree of influence of enzymes.

The creators of the pharmaceutical system of artificial intelligence compare the work of technology with the process of mastering a foreign language. First, the student learns the letters and tries to make words from them. The words in the pharmaceutical business are molecules. If the molecule is suitable and has all the necessary properties, the teacher accepts it. If not, it rejects, thereby motivating the student to prevent such mistakes in the future.